BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fukuba N, Ishihara S, Sonoyama H, Yamashita N, Aimi M, Mishima Y, Mishiro T, Tobita H, Shibagaki K, Oshima N, Moriyama I, Kawashima K, Miyake T, Ishimura N, Sato S, Kinoshita Y. Proton pump inhibitor is a risk factor for recurrence of common bile duct stones after endoscopic sphincterotomy - propensity score matching analysis. Endosc Int Open 2017;5:E291-6. [PMID: 28382327 DOI: 10.1055/s-0043-102936] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Takimoto Y, Irisawa A, Hoshi K, Yamamiya A, Nagashima K, Minaguchi T, Yamabe A, Izawa N, Haruyama Y, Tominaga K. The impact of endoscopic sphincterotomy incision size on common bile duct stone recurrence: A propensity score matching analysis. J Hepatobiliary Pancreat Sci 2021. [PMID: 34826207 DOI: 10.1002/jhbp.1083] [Reference Citation Analysis]
2 Wu Y, Xu CJ, Xu SF. Advances in Risk Factors for Recurrence of Common Bile Duct Stones. Int J Med Sci 2021;18:1067-74. [PMID: 33456365 DOI: 10.7150/ijms.52974] [Reference Citation Analysis]
3 Yang M, Xia B, Lu Y, He Q, Lin Y, Yue P, Bai B, Dong C, Meng W, Qi J, Yuan J. Association Between Regular Use of Gastric Acid Suppressants and Subsequent Risk of Cholelithiasis: A Prospective Cohort Study of 0.47 Million Participants. Front Pharmacol 2022;12:813587. [DOI: 10.3389/fphar.2021.813587] [Reference Citation Analysis]
4 Kamal H, Sadr-Azodi O, Engstrand L, Brusselaers N. Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study. Hepatology 2021;74:2021-31. [PMID: 34018229 DOI: 10.1002/hep.31914] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]